Category: Multiple Sclerosis

What to do if You Have a Multiple Sclerosis Relapse Explained by a Neurologist -. presented by @BrandonBeaber,MD

……………………………………………. Click to Subscribe for the MS Beacon eNewsletter, resources and MS education “““““““““““““““““““““  What should you do if you…

Stuart Schlossman

Women’s Health: Menopause and Multiple Sclerosis — presented by @AaronBoster,MD

  Click to Subscribe for the MS Beacon eNewsletter, resources and MS education . . Watch this video: Visit our…

Stuart Schlossman

Understanding more about MS relapse, MRI’s and Biomarkers for Multiple Sclerosis

 Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…

Stuart Schlossman

Learning more, about Multiple Sclerosis from the MS Beacon e-Newsletter

  Keep up-to-date with top releases about Multiple Sclerosis, Symptoms, treatments, diets, research and more, from the monthly online publication…

Stuart Schlossman

Multiple Sclerosis Coalition Applauds World Health Organization Decision

  Press Release Multiple Sclerosis Coalition Applauds World Health Organization Decision Decision to add MS treatments to Essential Medicines List…

Stuart Schlossman

Tendonitis and MS: Are They Connected?

  Multiple sclerosis (MS) can cause a wide range of symptoms, including pain in the muscles and joints (musculoskeletal pain). On MyMSTeam, the…

Stuart Schlossman

MS Bowel Problems: Ways To Manage Constipation and More

 Medically reviewed by Amit M. Shelat, D.O. Article written by  Victoria Menard The symptoms of multiple sclerosis (MS) can vary from person to person…

Stuart Schlossman

Bad Diet = 10X more Multiple Sclerosis!

 Information provided by Brandon Beaber, MD Does diet affect MS?  According to a study in Jordan, people who scored the…

Stuart Schlossman

Review: Ocrevus best of 4 antibody therapies for progressive MS

 Drug found most effective also only one approved for PPMS by FDA by Steve Bryson, PhD | June 27, 2023 Among four antibody-based…

Stuart Schlossman

Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials

 Click to Subscribe for the MS Beacon eNewsletter, resources and MS education                …

Stuart Schlossman

Categories

Latest Blog Posts